- Home
- NBTX vs HDSN Comparison
NBTX vs HDSN Comparison
Compare NBTX & HDSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- HDSN
- Stock Information
- Founded
- NBTX 2003
- HDSN 1991
- Country
- NBTX France
- HDSN United States
- Employees
- NBTX N/A
- HDSN N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- HDSN Industrial Specialties
- Sector
- NBTX Health Care
- HDSN Consumer Discretionary
- Exchange
- NBTX Nasdaq
- HDSN Nasdaq
- Market Cap
- NBTX 201.9M
- HDSN 241.2M
- IPO Year
- NBTX 2020
- HDSN 1994
- Fundamental
- Price
- NBTX $3.26
- HDSN $5.27
- Analyst Decision
- NBTX Strong Buy
- HDSN Hold
- Analyst Count
- NBTX 1
- HDSN 4
- Target Price
- NBTX $12.00
- HDSN $7.31
- AVG Volume (30 Days)
- NBTX 64.6K
- HDSN 644.0K
- Earning Date
- NBTX 12-31-2024
- HDSN 11-04-2024
- Dividend Yield
- NBTX N/A
- HDSN N/A
- EPS Growth
- NBTX N/A
- HDSN N/A
- EPS
- NBTX N/A
- HDSN 0.65
- Revenue
- NBTX $45,220,186.00
- HDSN $247,331,000.00
- Revenue This Year
- NBTX N/A
- HDSN N/A
- Revenue Next Year
- NBTX N/A
- HDSN N/A
- P/E Ratio
- NBTX N/A
- HDSN $8.14
- Revenue Growth
- NBTX 526.17
- HDSN N/A
- 52 Week Low
- NBTX $2.76
- HDSN $5.17
- 52 Week High
- NBTX $8.96
- HDSN $15.24
- Technical
- Relative Strength Index (RSI)
- NBTX 42.55
- HDSN 29.28
- Support Level
- NBTX $3.18
- HDSN $5.17
- Resistance Level
- NBTX $3.69
- HDSN $6.00
- Average True Range (ATR)
- NBTX 0.27
- HDSN 0.22
- MACD
- NBTX 0.07
- HDSN -0.01
- Stochastic Oscillator
- NBTX 56.45
- HDSN 16.84
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About HDSN Hudson Technologies Inc.
Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at a customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.